Shave, Punch, or Excisional: What Each Skin Biopsy Involves and Why Your Derm Picks One

One word, three operations

'We'll take a biopsy' is one of the most common sentences in dermatology and one of the least informative. It describes at least three distinct procedures that differ in the instrument used, how deep the sample goes, whether you leave with stitches, how long the site takes to heal, and what the resulting mark looks like a year later.

The practical consequence shows up weeks afterwards. Someone who had a shave biopsy ends up with a round, pale, slightly sunken patch and compares it with a colleague's thin white line from a punch, and concludes that something went wrong. Nothing went wrong. They had different operations, because they had different questions asked of their skin.

There is a single organising principle underneath the choice, and once you have it, the rest follows: the depth of the sample is determined by the depth of the answer. A dermatologist is not choosing a technique by habit or convenience. They are choosing the shallowest sample that can still answer the question they are actually asking — because the shallower the sample, the smaller the wound and the better the scar, right up until the point where shallow means wrong.

Shave biopsy: sampling the surface

A shave biopsy uses a flexible blade drawn tangentially through the skin, taking a saucer of tissue from the epidermis and upper dermis. It is quick, requires only local anaesthetic, and needs no sutures — bleeding is stopped with pressure, a chemical haemostatic, or cautery, and the wound is left to heal open.

It is the right tool when the diagnostic information lives at the surface. A raised lesion sitting proud of the skin, a suspected basal cell or squamous cell carcinoma, a seborrhoeic keratosis somebody wants confirmed, a wart-like growth of uncertain nature: in all of these, the architecture the pathologist needs is in the top layers, and going deeper adds a wound without adding information.

What it leaves is not a line. It is a round or oval mark, usually paler than surrounding skin, often slightly depressed — the divot people are surprised by. On a convex site like the shoulder or shin it can stay noticeable for a long time. That trade is deliberate: you get no stitches and no return visit for suture removal, at the cost of a mark with a different shape from the fine scar most people picture.

Healing takes roughly one to three weeks depending on the site, with legs consistently the slowest. The wound is an open one during that period, and the standard instruction is to keep it moist and covered rather than to let it scab hard — a plain ointment such as Aquaphor Healing Ointment under a simple dressing, changed as your clinician directs.

One important limitation, which the next section explains properly: a shave that goes deep enough to remove a lesion entirely is a different thing from one that skims a fragment off the top, and for pigmented lesions the distinction matters enormously.

Punch biopsy: full thickness, and the workhorse for rashes

A punch biopsy uses a circular cutting tool — a small cylindrical blade, typically between two and six millimetres across — rotated through the skin to remove a full-thickness core: epidermis, the whole dermis, and usually a little subcutaneous fat.

This is the standard approach for rashes and inflammatory skin disease, and the reason is architectural. When a pathologist distinguishes between psoriasis, eczema, lichen planus, a drug eruption and a cutaneous lymphoma, the features they rely on are patterns of inflammation at particular depths — which cells are clustered around which structures, at what level of the dermis, with what changes above them. A shave biopsy of a rash frequently returns a report that says, in effect, that inflammation is present and the specimen is too superficial to classify it. That is a wasted procedure and a repeated appointment.

Site selection matters as much as technique here. For a rash, a clinician generally wants an active, established lesion rather than a scratched, treated or resolving one, and often avoids the lower legs where healing is slowest and background changes can confuse the picture. If you have been applying a steroid to the area, say so — it alters the histology.

A punch site is usually closed with one or two sutures, removed after about five to seven days on the face and up to ten to fourteen days on the trunk and limbs. The resulting scar is small: a short line where the round defect was closed, or occasionally a small round mark if it was left to heal open.

The punch tool has a second life in scar treatment rather than diagnosis — punch excision remains part of the toolkit for certain deep, narrow acne scars, which ↗our answer on punch excision for icepick scars covers. And if you are wondering whether a persistent bumpy eruption warrants sampling at all, ↗the answer on when a biopsy is needed is worth reading before the appointment.

Excisional biopsy: taking the whole thing on the first pass

An excisional biopsy removes the entire lesion, usually as an ellipse with a narrow margin of normal-looking skin around it, closed with a layer of sutures.

It is chosen when the pathologist needs to see the whole lesion rather than a representative piece — most importantly when melanoma is suspected, and also for lesions where the relationship between the centre and the edge is itself diagnostic, or where a partial sample has already come back equivocal.

Two things surprise patients about excisions. The first is that the incision is considerably longer than the lesion. An ellipse needs a length-to-width ratio of roughly three to one to close without leaving a raised bunching at each end, so removing a lesion the size of a pencil eraser can produce a scar several centimetres long. That is geometry, not overreach.

The second is that an excisional biopsy is a diagnostic procedure, not necessarily a definitive treatment. If it confirms melanoma, a wider local excision usually follows, taking a further margin determined by how deep the tumour went. Being told you need a second operation on a lesion that has already been removed is not a sign that the first one failed — it was never intended to be the final margin.

Sutures come out on the usual schedule, and the scar goes through the same remodelling as any surgical line: firm and pink for the first month or two, then flattening and fading over a year. Sun protection during that window genuinely matters, because ultraviolet exposure on immature scar tissue drives lasting redness and pigmentation. A well-tolerated mineral formula such as Vanicream Mineral Sunscreen is the usual suggestion once the wound is closed.

Why melanoma changes the rules

This is the section that justifies the whole article, and it turns on one measurement.

Melanoma staging depends heavily on Breslow thickness — the depth from the top of the granular layer to the deepest identifiable tumour cell, measured in millimetres. That single number drives how wide the subsequent excision margin should be and whether a sentinel lymph node biopsy is discussed. It is not a detail; it is the axis the management plan is built on.

Now consider what a partial sample does to it. If you shave off the top of a pigmented lesion, or punch a core out of the middle of it, you may simply miss the deepest part of the tumour. The pathologist measures what they are given, and what they are given may be transected at its base — so the reported thickness can understate the real one. Downstream, that can mean a narrower margin than the tumour warranted, or a sentinel node discussion that never happened.

There is also a diagnostic accuracy problem, and it has been quantified. A retrospective study drawing on a melanoma service database examined false-negative and false-positive melanoma diagnoses over several years. Partial shave biopsy carried roughly five-fold higher odds of a false-negative melanoma diagnosis compared with elliptical excisional biopsy, with the odds for incisional punch biopsy comparable. Both techniques also raised the odds of a false-positive.

The same study produced a finding that has nothing to do with the blade at all, and it may be the most useful thing here: providing the suspected clinical diagnosis to the pathologist on the request form reduced the odds of a false-negative diagnosis associated with disease progression by about 3.8-fold. A pathologist reading a slide labelled 'lesion, back' is working blind compared with one told that the clinician suspects melanoma in a changing pigmented lesion. The paperwork is part of the diagnosis.

And now the honest caveat, because the rule is not absolute. Partial sampling of a suspected melanoma is sometimes the correct clinical decision — for a very large lesion, for one on a functionally or cosmetically critical site such as the face or the nail unit, or for lentigo maligna where the borders are indistinct and a complete excision would be disfiguring before a diagnosis is even confirmed. Guidelines accommodate this. The principle is that complete excisional biopsy with a narrow margin is preferred where practical, and that when it is not practical the clinician is making a considered trade rather than a mistake. If your lesion is being sampled partially and you want to understand why, that is a fair and answerable question to ask in the room.

What to ask before you leave, and what to do while you wait

Four questions, none of which takes more than a few seconds, and all of which are routinely left unasked.

Which type of biopsy did I have? Knowing whether it was a shave, punch or excision tells you what to expect from healing and lets you make sense of the report when it arrives.

Which lesion, exactly, and where? Ask them to point, and consider photographing the site before you leave. If more than one thing was sampled, or if a second procedure follows, unambiguous site identification prevents the most avoidable error in the whole process. Our mole map exists partly for this, and the ABCDE check is the reference for what made the lesion worth sampling in the first place.

How and when will I get the result, and what happens if I hear nothing? The second half of that question matters more than the first. Results going astray is a real failure mode, and 'no news is good news' is not a safe assumption. Agree a date by which you will chase.

And what do I do with the wound? Get the specifics — how long to keep it covered, what to put on it, when you can shower, when sutures come out, and what would count as infection. The general principle across all three techniques is that wounds heal better moist than dry, which is why a plain ointment like CeraVe Healing Ointment under a dressing is the standard instruction rather than an antibiotic cream — topical antibiotic ointments are a well-documented cause of allergic contact dermatitis on healing skin. Once the wound has closed, keeping the area clean with something bland such as Vanicream Gentle Facial Cleanser is all that is required.

The waiting is the hard part, and it is worth naming that. Turnaround is typically one to two weeks and can be longer if the specimen goes for additional stains or a second opinion — which, counterintuitively, often means the case is being taken seriously rather than that something is wrong. ↗Our answer on waiting for a biopsy result deals with that stretch directly. Our derm visit prep tool will help you arrive with the questions written down, which is the difference between leaving informed and leaving with a dressing and a vague sense of unease.